CURE Pharmaceutical Holding Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 192,000 compared to USD 102,000 a year ago. Operating loss was USD 2.772 million compared to operating Income of USD 2.071 million a year ago. Net loss was USD 2.751 million compared to net income of USD 2.204 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to basic earnings per share from continuing operations of USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to diluted earnings per share from continuing operations of USD 0.05 a year ago. For the nine months, total revenue was USD 741,000 compared to USD 284,000 a year ago. Operating loss was USD 14.258 million compared to USD 12.740 million a year ago. Net loss was USD 14.144 million compared to USD 20.472 million a year ago. Basic loss per share from continuing operations was USD 0.32 compared to USD 0.62 a year ago.